Expertise in
10
conditions

Dr. James P. Wymer

Neurology
Florida Clinical Practice Association Inc
1600 Sw Archer Rd, 
Gainesville, FL 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
Florida Clinical Practice Association Inc
1600 Sw Archer Rd, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Wymer is a Neurologist in Gainesville, Florida. Dr. Wymer is highly rated in 10 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 3, Spinal and Bulbar Muscular Atrophy, and Gastrostomy. Dr. Wymer is currently accepting new patients.

His clinical research consists of co-authoring 58 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health First
  • HMO
  • POS
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1600 Sw Archer Rd, Gainesville, FL 32610
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
3009 Sw Williston Rd, Uf Health Digestive Disease Specialist, Gainesville, FL 32608
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2000 Sw Archer Rd, Uf Health Congenital Heart Center Medi, Gainesville, FL 32610
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Center, Gainesville, FL 32608

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
A Pragmatic Trial to Evaluate the Intermediate-term Effects of Early, Aggressive Versus Escalation Therapy in People With Multiple Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: May 30, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Participants With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Other, Biological
Study Phase: Phase 3
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Long-term, Prospective, Non-interventional, Extension of a Phase III, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety & Efficacy of Engensis (VM202) in Subjects With Painful Diabetic Peripheral Neuropathy
Enrollment Status: Completed
Publish Date: February 25, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment
Enrollment Status: Active_not_recruiting
Publish Date: October 18, 2024
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 2
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran
An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 4
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
A Multi-Center, Open Label Study to Assess the Safety and Tolerability of Riluzole Oral Soluble Film in Subjects With Amyotrophic Lateral Sclerosis Over 12 Weeks of Twice Daily Treatment.
Enrollment Status: Withdrawn
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 8 Less Clinical Trials

58 Total Publications

Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: May 14, 2025
Similar Doctors
Expertise in
26
conditions
Dr. Michael S. Okun
Neurology
Expertise in
26
conditions
Dr. Michael S. Okun
Neurology

Florida Clinical Practice Association Inc

1600 Sw Archer Rd, Suite 100371, 
Gainesville, FL 
 (0.1 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Okun is a Neurologist in Gainesville, Florida. Dr. Okun is highly rated in 26 conditions, according to our data. His top areas of expertise are Movement Disorders, Parkinson's Disease, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Okun is currently accepting new patients.

Expertise in
32
conditions
Dr. Tetsuo Ashizawa
Neurology
Expertise in
32
conditions
Dr. Tetsuo Ashizawa
Neurology
1600 Sw Archer Rd, 
Gainesville, FL 
 (0.1 mi)
352-273-5550
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tetsuo Ashizawa is a Neurologist in Gainesville, Florida. Dr. Ashizawa is highly rated in 32 conditions, according to our data. His top areas of expertise are Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 10, Spinocerebellar Ataxia, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Ashizawa is currently accepting new patients in some locations.

Expertise in
27
conditions
Dr. Nikolaus R. Mcfarland
Neurology | Psychiatry
Expertise in
27
conditions
Dr. Nikolaus R. Mcfarland
Neurology | Psychiatry

Florida Clinical Practice Association Inc

1600 Sw Archer Rd, Suite 100371, 
Gainesville, FL 
 (0.1 mi)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nikolaus Mcfarland is a Neurologist and a Psychiatrist in Gainesville, Florida. Dr. Mcfarland is highly rated in 27 conditions, according to our data. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Movement Disorders, Parkinson's Disease, and Deep Brain Stimulation. Dr. Mcfarland is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wymer's expertise for a condition
ConditionClose
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile